Why the Same Peptide Gets Different Quotes

Two quotes for the same research peptide land in the same inbox on the same day with a gap that no currency conversion explains. The difference is almost always a proxy for something concrete: a different purity specification, a different kind of certificate attached to the batch, or a cost that one supplier includes and the other quietly omits. Cold-chain packaging, independent laboratory analysis, and import documentation each carry a real price — one that shows up in the quote, or surfaces later.

Purity is the main driver

A research peptide can be quoted at 95% HPLC purity or at 99% HPLC purity. Both are "the same peptide" by name. The production cost is not the same, because moving a lot from 95% to 99% requires additional purification passes: more column time, lower yield per run, and a higher rate of batch rejection.

A supplier buying 95% starting material pays a different input cost than one buying 99% material. If the second supplier also sends each lot to an independent laboratory for a verified purity number, that cost adds again.

In the four lots published on PeptoClinic's quality page, all analysed by Janoshik Analytical on 13 April 2026, the lowest purity found across the four results was 99.669%. That figure is in the signed report, traceable by task number at the laboratory's own site. It is not a label claim — it is the result of an HPLC analysis run on a specific, identified lot.

The certificate of analysis is not a standard document

Any supplier can issue a certificate of analysis. The relevant question is who signed it and under what conditions.

A CoA issued internally by the same supplier selling the material is a self-reported claim. A CoA issued by an independent laboratory with a task number traces the result to a party that has no financial interest in the outcome. Both documents can look similar in a PDF, but they do not offer the same assurance.

The elements that make a CoA useful rather than decorative:

• The name and address of the analysing laboratory
• A task or report number that allows the result to be looked up directly at the laboratory's site
• The declared analytical method — HPLC, mass spectrometry, NMR
• A numerical purity result, not a binary pass/fail

When a supplier publishes a CoA without a task number and without an identifiable laboratory, the lower price often reflects exactly that: the absence of the analysis cost.

Declared content versus what is actually in the vial

A vial labelled 10 mg may contain 10 mg, 9.1 mg, or 11.96 mg. The difference between declared and actual content is not an implied tolerance — it is information a researcher needs to know what they received and to calculate amounts accordingly.

In task report 136921, Janoshik Analytical found 11.96 mg in a vial of retatrutide labelled as 10 mg. In task 136923, the same laboratory found 11.31 mg in a 10 mg vial of MOTS-c. That overfill is declared because the material is for laboratory research and the researcher needs the actual quantity on record.

A supplier absorbing overfill at its own cost has different input economics from one that hits the exact declared weight, and both differ from one that underfills and relies on the label as the only measure. None of those differences appear on the product line of the quote.

Cold chain adds to the price

Lyophilised peptides are stable at room temperature during short transits, but correct handling means refrigerated storage and thermally appropriate packaging for longer routes. That packaging has a direct cost.

A supplier shipping at ambient temperature without cold-chain packing can quote lower because that cost is not being absorbed. The gap in the final number reflects who is paying for cold chain and who is not.

For destinations such as Argentina, where material enters with specific import documentation prepared for laboratory reference material, cold-chain logistics integrate with the documentation process. A supplier without experience in that market may not price those elements into their quote because they are simply outside their standard operation.

Import documentation shows up in the quote

Argentina has an import process for laboratory reference material that is not the same as receiving a shipment from a domestic reagent supplier. The correct tariff code, the technical documentation customs requires, and prior experience with that process all carry a cost — one the supplier absorbs or passes on.

A supplier that has already resolved that process quotes with that work included. Details on destinations served and how the import process is handled are on PeptoClinic's shipping page.

A supplier that has not resolved it quotes a price that does not include resolving it. That cost appears later: in a customs process the buyer handles alone, or in a shipment held at the border.

Differences that do not appear in the number

Two quotes for BPC-157 can differ because:

• The base material was produced to different HPLC purity specifications
• One carries a third-party CoA with a verifiable task number and the other does not
• One includes import documentation prepared for the destination and the other does not
• Cold-chain packaging is absorbed in one quote and excluded from the other
• The lot number in one allows traceability to a signed external report and in the other it does not

When price is the only visible variable, none of those differences appear in the comparison. They appear after the material ships — or does not.

For laboratory research only

All material quoted by PeptoClinic is intended strictly for in vitro and laboratory research (Research Use Only). It is not approved for, intended for, or supplied for human or veterinary use. No regulatory authority — the FDA, ANMAT, or any equivalent — has evaluated this material for any therapeutic indication. Requests about dosing, protocols, or administration in people fall outside the scope of this consultancy.